These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2347132)

  • 1. Destructive lesions of small joints in seronegative spondylarthropathies: relation to gut inflammation.
    Mielants H; Veys EM; Goethals K; Van Der Straeten C; Ackerman C
    Clin Exp Rheumatol; 1990; 8(1):23-7. PubMed ID: 2347132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical involvement of the gut in undifferentiated spondylarthropathies.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Clin Exp Rheumatol; 1989; 7(5):499-504. PubMed ID: 2591124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destructive hip lesions in seronegative spondyloarthropathies: relation to gut inflammation.
    Mielants H; Veys EM; Goethals K; Van der Straeten C; Ackerman C; Goemaere S
    J Rheumatol; 1990 Mar; 17(3):335-40. PubMed ID: 2332855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Botelberghe L
    J Rheumatol; 1985 Apr; 12(2):294-8. PubMed ID: 3875721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ileocolonoscopic findings in seronegative spondylarthropathies.
    Mielants H; Veys EM; Cuvelier C; de Vos M
    Br J Rheumatol; 1988; 27 Suppl 2():95-105. PubMed ID: 3042080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation.
    Mielants H; Veys EM; Joos R; Noens L; Cuvelier C; De Vos M
    J Rheumatol; 1987 Jun; 14(3):466-71. PubMed ID: 3498033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset pauciarticular juvenile chronic arthritis: relation to gut inflammation.
    Mielants H; Veys EM; Joos R; Cuvelier C; De Vos M; Proot F
    J Rheumatol; 1987 Jun; 14(3):459-65. PubMed ID: 3498032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Articular diseases and the gut: evidence for a strong relationship between spondylarthropathy and inflammation of the gut in man.
    De Vos M
    Acta Clin Belg; 1990; 45(1):20-4. PubMed ID: 2161601
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
    Mielants H; Veys EM; De Vos M; Cuvelier C; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2266-72. PubMed ID: 8835560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation.
    De Keyser F; Van Damme N; De Vos M; Mielants H; Veys EM
    Inflamm Res; 2000 Feb; 49(2):47-54. PubMed ID: 10738942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of gut inflammation in spondylarthropathies and therapeutic consequences.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):147-64. PubMed ID: 8674145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ileocolonoscopy in seronegative spondylarthropathy.
    De Vos M; Cuvelier C; Mielants H; Veys E; Barbier F; Elewaut A
    Gastroenterology; 1989 Feb; 96(2 Pt 1):339-44. PubMed ID: 2637670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
    Mielants H; De Vos M; Cuvelier C; Veys EM
    Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy.
    Cuvelier C; Mielants H; De Vos M; Veys E; Roels H
    Gut; 1990 May; 31(5):545-9. PubMed ID: 2351304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; Maertens M; Joos R
    J Rheumatol; 1993 Sep; 20(9):1567-72. PubMed ID: 8164217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Articular manifestations of inflammatory bowel disease].
    Mauro-Filho Gde L; Ribeiro S
    Arq Gastroenterol; 1985; 22(4):186-91. PubMed ID: 3837658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.